Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle control of BRCA2

J P Vaughn1, F D Cirisano, G Huper

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Cancer Research
|October 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic gene expression signature for high-grade serous ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.

Gynecologic oncology·2020
Same author

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Science (New York, N.Y.)·2017
Same author

LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2015
Same author

Agreement between specially trained and accredited optometrists and glaucoma specialist consultant ophthalmologists in their management of glaucoma patients.

Eye (London, England)·2012
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

BRCA2 gene expression is regulated by the cell cycle and linked to cell proliferation in breast cells. Its mRNA levels peak during late G1 and S-phase, suggesting a role in cellular growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The BRCA2 gene is a crucial tumor suppressor.
  • Understanding BRCA2 gene expression is key to its function in preventing cancer.
  • Its regulation by the cell cycle is not fully understood.

Purpose of the Study:

  • To investigate the cell cycle regulation of BRCA2 gene expression.
  • To determine the kinetics of BRCA2 mRNA induction.
  • To explore the relationship between BRCA2 expression and cell proliferation.

Main Methods:

  • Analysis of BRCA2 mRNA levels in normal and tumor-derived breast epithelial cells.
  • Cell cycle synchronization using G0/G1 arrest and release.
  • Isolation of exponentially growing cells via centrifugal elutriation.

Related Experiment Videos

Main Results:

  • BRCA2 mRNA levels are low in G0/G1 phases and increase significantly in late G1 and S-phase.
  • BRCA2 expression is cell cycle-dependent and associated with proliferation.
  • BRCA2 mRNA up-regulation kinetics resemble those of BRCA1, suggesting co-regulation.
  • BRCA2 expression is independent of bulk DNA synthesis.

Conclusions:

  • BRCA2 is regulated by the cell cycle, with peak expression during active proliferation.
  • BRCA2 and BRCA1 may share common regulatory mechanisms.
  • These findings suggest BRCA2 plays a protective role during cellular growth and proliferation.